source
- Merck and Moderna disclose phase 3 cancer vaccine data early after leak, showing improved recurrence-free survival with KeytrudaMerck & Co. and Moderna were forced to release their phase 3 trial results for the intismeran autogene cancer vaccine two days ahead of schedule after an unexpected leak of the data ahead of the ES…
- Merck and Moderna present Phase 3 cancer vaccine data at ESMO26 amid Treasury proposal on China investmentEndpoints Weekly reporter Nicole DeFeudis writes from Madrid during the ESMO26 meeting. The most anticipated presentation was a Phase 3 study of a cancer vaccine jointly developed by Merck and Mod…